Abiopharma

New Form SCHEDULE 13G/A - Cytek Biosciences, Inc. Filed: 2025-05-15 AccNo: 0001398344-25-009599 Size: 7 KB

New Form SCHEDULE 13G/A - IMMUNIC, INC. Filed: 2025-05-15 AccNo: 0000919574-25-003220 Size: 25 KB

New Form SCHEDULE 13G/A - Kalaris Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0000935836-25-000363 Size: 15 KB

New Form SCHEDULE 13G/A - Immunome Inc. Filed: 2025-05-15 AccNo: 0000935836-25-000362 Size: 15 KB

New Form SCHEDULE 13G/A - Inogen Inc Filed: 2025-05-15 AccNo: 0001398344-25-009596 Size: 7 KB

New Form 10-Q - RETRACTABLE TECHNOLOGIES INC Filed: 2025-05-15 AccNo: 0001558370-25-007853 Size: 5 MB

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments

New Form 10-Q - Jaguar Health, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072367 Size: 20 MB

New Form SCHEDULE 13G/A - ARVINAS, INC. Filed: 2025-05-15 AccNo: 0000935836-25-000359 Size: 15 KB

New Form 10-Q - ALTAIR INTERNATIONAL CORP. Filed: 2025-05-15 AccNo: 0001683168-25-003676 Size: 3 MB

New Form SCHEDULE 13G/A - Aligos Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0000935836-25-000358 Size: 16 KB

FDA approve AVUTOMETINIB

New Form 8-K - Incannex Healthcare Inc. Filed: 2025-05-15 AccNo: 0001213900-25-044002 Size: 232 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13D - FARO TECHNOLOGIES INC Filed: 2025-05-15 AccNo: 0001104659-25-049256 Size: 77 KB

New Form 144 - ENSIGN GROUP, INC Filed: 2025-05-15 AccNo: 0001959173-25-003218 Size: 6 KB